Abstract
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Roberto Gerli, Claudio Lunardi, Elena Bartoloni Bocci, Francesca Bobbio-Pallavicini, Giuseppe Schillaci, Roberto Caporali, Onelia Bistoni, Matteo Pirro, Costantino Pitzalis and Carlomaurizio Montecucco
The Journal of Rheumatology January 2008, 35 (1) 14-19;
Roberto Gerli
Claudio Lunardi
Elena Bartoloni Bocci
Francesca Bobbio-Pallavicini
Giuseppe Schillaci
Roberto Caporali
Onelia Bistoni
Matteo Pirro
Costantino Pitzalis
Carlomaurizio Montecucco
In this issue
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Roberto Gerli, Claudio Lunardi, Elena Bartoloni Bocci, Francesca Bobbio-Pallavicini, Giuseppe Schillaci, Roberto Caporali, Onelia Bistoni, Matteo Pirro, Costantino Pitzalis, Carlomaurizio Montecucco
The Journal of Rheumatology Jan 2008, 35 (1) 14-19;
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Roberto Gerli, Claudio Lunardi, Elena Bartoloni Bocci, Francesca Bobbio-Pallavicini, Giuseppe Schillaci, Roberto Caporali, Onelia Bistoni, Matteo Pirro, Costantino Pitzalis, Carlomaurizio Montecucco
The Journal of Rheumatology Jan 2008, 35 (1) 14-19;